SEC Form 4 · accession 0001104659-18-000222
PRA Health Sciences, Inc. · PRAH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David W Dockhorn
Officer — Executive Vice President & CCO
Period of report
Dec 28, 2017
Accepted (ET)
Jan 2, 2018 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613859
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 28, 2017 | M | 72,850 | $11.73 | A | 72,850 | D | |
| Common StockF2 | Dec 28, 2017 | S | 68,614 | $90.81 | D | 4,236 | D | |
| Common StockF3 | Dec 28, 2017 | S | 4,236 | $91.22 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $11.73 | Dec 28, 2017 | M | 72,850 | D | — | Dec 20, 2023 | Common Stock | 72,850 | 12,422 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $90.16 to $91.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $91.15 to $91.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F442,636 of the options vested on March 2, 2016 upon satisfaction of certain performance criteria and 30,214 of the options vested on November 16, 2016 upon satisfaction of certain other performance criteria.